NewsIcosavax Soars as AstraZeneca Announces Acquisition Deal By InvestLuck December 12, 2023 1 Mins read Icosavax, a Seattle-based vaccine developer, experienced a significant boost in stock prices, surging by 47% in premarket trading on Tuesday. The reason… Read more
